Related references
Note: Only part of the references are listed.Integrated analysis of multimodal single-cell data
Yuhan Hao et al.
CELL (2021)
Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease
Annalisa Lattanzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
ATF4 Regulates MYB to Increase γ-Globin in Response to Loss of β-Globin
Mandy Y. Boontanrart et al.
CELL REPORTS (2020)
Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates
Zulema Romero et al.
MOLECULAR THERAPY (2019)
In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods
Sowmya Pattabhi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Low-Dose Busulfan Reduces Human CD34+ Cell Doses Required for Engraftment in c-kit Mutant Immunodeficient Mice
Alexis Leonard et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
What can we learn from ineffective erythropoiesis in thalassemia?
Paraskevi Rea Oikonomidou et al.
BLOOD REVIEWS (2018)
Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells
Joseph Long et al.
MOLECULAR THERAPY (2018)
Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements
Michael Kosicki et al.
NATURE BIOTECHNOLOGY (2018)
p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells
Robert J. Ihry et al.
NATURE MEDICINE (2018)
CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response
Emma Haapaniemi et al.
NATURE MEDICINE (2018)
Inter-homologue repair in fertilized human eggs?
Dieter Egli et al.
NATURE (2018)
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
Christopher A. Vakulskas et al.
NATURE MEDICINE (2018)
Promise of gene therapy to treat sickle cell disease
Zulema Romero et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2018)
Gene Therapy in a Patient with Sickle Cell Disease
Jean-Antoine Ribeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sickle Cell Disease
Frederic B. Piel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
CRISPR-Cas9 gene repair of hematopoietic stem cells from patients with X-linked chronic granulomatous disease
Suk See De Ravin et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
A machine learning approach for predicting CRISPR-Cas9 cleavage efficiencies and patterns underlying its mechanism of action
Shiran Abadi et al.
PLOS COMPUTATIONAL BIOLOGY (2017)
Allogeneic bone marrow transplant in the absence of cytoreductive conditioning rescues mice with β-thalassemia major
Yongliang Huo et al.
BLOOD ADVANCES (2017)
At least 20% donor myeloid chimerism is necessary to reverse the sickle phenotype after allogeneic HSCT
Courtney D. Fitzhugh et al.
BLOOD (2017)
Preclinical studies for a phase 1 clinical trial of autologous hematopoietic stem cell gene therapy for sickle cell disease
Fabrizia Urbinati et al.
CYTOTHERAPY (2017)
Developmentally-faithful and effective human erythropoiesis in immunodeficient and Kit mutant mice
Claudia Fiorini et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Rationally engineered Cas9 nucleases with improved specificity
Ian M. Slaymaker et al.
SCIENCE (2016)
Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease
Mark C. Walters et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells
Megan D. Hoban et al.
MOLECULAR THERAPY (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Benjamin P. Kleinstiver et al.
NATURE (2016)
Analyzing CRISPR genome-editing experiments with CRISPResso
Luca Pinello et al.
NATURE BIOTECHNOLOGY (2016)
Near-optimal probabilistic RNA-seq quantification
Nicolas L. Bray et al.
NATURE BIOTECHNOLOGY (2016)
Mechanism and regulation of the nonsense-mediated decay pathway
Nele Hug et al.
NUCLEIC ACIDS RESEARCH (2016)
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
Mark A. DeWitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Fetal hemoglobin regulation in β-thalassemia: heterogeneity, modifiers and therapeutic approaches
Orapan Sripichai et al.
EXPERT REVIEW OF HEMATOLOGY (2016)
Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR
Maximilian Haeussler et al.
GENOME BIOLOGY (2016)
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
Megan D. Hoban et al.
BLOOD (2015)
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Ayal Hendel et al.
NATURE BIOTECHNOLOGY (2015)
Nonirradiated NOD,B6.SCID Il2rγ-/- KitW41/W41 (NBSGW) Mice Support Multilineage Engraftment of Human Hematopoietic Cells
Brian E. McIntosh et al.
STEM CELL REPORTS (2015)
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Shengdar Q. Tsai et al.
NATURE BIOTECHNOLOGY (2015)
Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery
Steven Lin et al.
ELIFE (2014)
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2013)
Smart-seq2 for sensitive full-length transcriptome profiling in single cells
Simone Picelli et al.
NATURE METHODS (2013)
CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activity
Thomas J. Cradick et al.
NUCLEIC ACIDS RESEARCH (2013)
Ineffective Erythropoiesis in β-Thalassemia
Jean-Antoine Ribeil et al.
SCIENTIFIC WORLD JOURNAL (2013)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
Quantitatively different red cell/nucleated cell chimerism in patients with long-term, persistent hematopoietic mixed chimerism after bone marrow transplantation for thalassemia major or sickle cell disease
Marco Andreani et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Evidence for ineffective erythropoiesis in severe sickle cell disease
CJ Wu et al.
BLOOD (2005)
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia
R Iannone et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia
MC Walters et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2001)
Long-term survive of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation
M Andreani et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
